OA09440A - "Transformed shigella". - Google Patents

"Transformed shigella".

Info

Publication number
OA09440A
OA09440A OA59749A OA59749A OA09440A OA 09440 A OA09440 A OA 09440A OA 59749 A OA59749 A OA 59749A OA 59749 A OA59749 A OA 59749A OA 09440 A OA09440 A OA 09440A
Authority
OA
OAPI
Prior art keywords
shigella
transformed
transformed shigella
Prior art date
Application number
OA59749A
Other languages
English (en)
Inventor
Sansonetti Philippe
Fontaine Annick
Original Assignee
Inst Pasteur & I National De L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88401842.5A external-priority patent/EP0350555A1/en
Application filed by Inst Pasteur & I National De L filed Critical Inst Pasteur & I National De L
Publication of OA09440A publication Critical patent/OA09440A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
OA59749A 1988-07-15 1990-03-14 "Transformed shigella". OA09440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88401842.5A EP0350555A1 (en) 1988-07-15 Transformed shigella

Publications (1)

Publication Number Publication Date
OA09440A true OA09440A (en) 1992-10-15

Family

ID=8200405

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59749A OA09440A (en) 1988-07-15 1990-03-14 "Transformed shigella".

Country Status (15)

Country Link
US (2) US7138126B2 (da)
EP (1) EP0351322B1 (da)
JP (3) JP3608742B2 (da)
KR (1) KR900702025A (da)
AR (1) AR242989A1 (da)
AT (1) ATE106941T1 (da)
AU (1) AU620630B2 (da)
CA (1) CA1324970C (da)
DE (1) DE68915876T2 (da)
DK (1) DK175464B1 (da)
ES (1) ES2054058T3 (da)
OA (1) OA09440A (da)
PT (1) PT91177B (da)
WO (1) WO1990000604A1 (da)
ZA (1) ZA895371B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR242989A1 (es) * 1988-07-15 1993-06-30 Inst Pasteur I Nat De La Sante Metodo para modificar una cepa salvaje de una shigella entero-invasora para producir una cepa modificada apta para preparar una vacuna contra la cepa salvaje y cepa de shigella asi modificada.
ATE111957T1 (de) * 1990-02-06 1994-10-15 Pasteur Institut Transformiertes shigella.
SG46987A1 (en) * 1992-04-10 1998-03-20 Schweiz Serum & Impfinst Recombinant live vaccines
IL123569A (en) * 1995-09-06 2006-10-05 Dept Of The Army Attenuated shigella strain for delivering a mamalian expression plasmid into a mammalian cell
CN101720229A (zh) * 2007-04-25 2010-06-02 以沃尔特里德军事研究所的名义,由美国陆军部部长为代表的美国政府 活减毒志贺氏菌疫苗株基因缺失组合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US5762941A (en) * 1988-07-15 1998-06-09 Institut Pasteur Modified shigella having reduced pathogenicity
AR242989A1 (es) * 1988-07-15 1993-06-30 Inst Pasteur I Nat De La Sante Metodo para modificar una cepa salvaje de una shigella entero-invasora para producir una cepa modificada apta para preparar una vacuna contra la cepa salvaje y cepa de shigella asi modificada.

Also Published As

Publication number Publication date
JP2005013234A (ja) 2005-01-20
AR242989A1 (es) 1993-06-30
JP3608742B2 (ja) 2005-01-12
DE68915876T2 (de) 1994-09-22
US7138126B2 (en) 2006-11-21
EP0351322A1 (en) 1990-01-17
US20050031644A1 (en) 2005-02-10
JP4277957B2 (ja) 2009-06-10
CA1324970C (en) 1993-12-07
EP0351322B1 (en) 1994-06-08
ES2054058T3 (es) 1994-08-01
DE68915876D1 (de) 1994-07-14
PT91177A (pt) 1990-02-08
WO1990000604A1 (en) 1990-01-25
US7439053B2 (en) 2008-10-21
AU3879589A (en) 1990-02-05
DK65790D0 (da) 1990-03-13
PT91177B (pt) 1995-09-12
ATE106941T1 (de) 1994-06-15
JP2006280378A (ja) 2006-10-19
US20060257940A1 (en) 2006-11-16
JPH03500368A (ja) 1991-01-31
KR900702025A (ko) 1990-12-05
DK65790A (da) 1990-03-13
DK175464B1 (da) 2004-11-01
AU620630B2 (en) 1992-02-20
ZA895371B (en) 1990-04-25

Similar Documents

Publication Publication Date Title
AU103615S (en) 20 july 1988
HU9202848D0 (en) 1,2-dihydro-2-oxopyridine
ZA895085B (en) New substituted 1,7-annelated 1h-indizoles
AR244666A1 (es) Procedimiento para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como analgesicos y relajantes musculares.
GB2225121B (en) "camera having selective functions"
EP0481950A3 (en) 1,4-dideoxy-4-fluoronojirimycin
OA09440A (en) "Transformed shigella".
OA09231A (en) "Detergent composition".
ZA895454B (en) 2,2-dihalogenocy-clopropyl-hydroxy-ethyltriazoles
GB2200845B (en) "teat-treating emulsions".
OA09243A (en) "Synthèse peptidique en phase solide".
ZA891059B (en) 1-aminomethyl-3-(2,4-difluoro-3-chlorophenyl)-4-cyano-pyrroles
PL275205A1 (en) Dvigatel' vnutrennego sgoranija
ZA899666B (en) 'n verfroller
CS22787A1 (en) Zpusob pripravy 2,6-dialkoxybenzonitrilu
IE882166L (en) 11ß-PHENYL-4,9,15-ESTRATRIENES
IE883873L (en) 1-aralkyl-1,2,-dihydropyrimidine-2-thiones
IE881897L (en) 2, 2-dimethylchroman-3-ols
IE881104L (en) 2,3-bicyclopyrazolidinones
CS267188A1 (en) 1,2,2,6,6-pentamethyl-4-allyloxypiperidine
IE881998L (en) 1 h-pyrazole-1-alkanamides
GB9121194D0 (en) The"gapco"
HU906221D0 (en) "tuti-toto"
HU901400D0 (en) Logic - toy "gurul 6"
IE900472L (en) 2,3,23-trihydroxy-urs-12-ene